Novo Nordisk’s Magic Run Continues Even With Increasing Competition
Novo Nordisk’s Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
Mindfully Curated
Novo Nordisk’s Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
Novo Nordisk’s Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
These two low-priced large-cap stocks sport ginormous yields.
These two low-priced large-cap stocks sport ginormous yields.
PayPal’s earnings forecast for 2024 disappointed stock market investors.
PayPal’s earnings forecast for 2024 disappointed stock market investors.
Palantir CEO Alex Karp sounded extremely confident in the company’s future, given its leadership in artificial intelligence.
Palantir CEO Alex Karp sounded extremely confident in the company’s future, given its leadership in artificial intelligence.
Tread carefully with ultra-high yields — though some of these might be worth taking a chance on.
Here’s exactly how much other retirees are receiving in benefits.
The drugmaker continues to impress investors.
The phrase “easier said than done” applies to all three challenges.
Buying and holding growth stocks can pay big dividends over the long term.
It’s less scary to take on risky investments when the market is rising.
It’s been a long road for Uber, but its recent reinvention is paying off — good news for investors.
JD’s stock is not for the fainthearted.
These fast-growing companies could be your ticket to market-beating returns.
Enbridge offers investors superior income, growth visibility, and financial strength.
These stocks offer yields significantly above the S&P 500 average.
There are some stocks this Fool owns and plans to hold for decades. Here are three of his favorites.